Gem Hopkins
Investor Relations Kontakt bei SILENCE THERAPEUTICS PLC
Profil
Gem Hopkins is currently working as the VP-Investor Relations & Corporate Communications at Silence Therapeutics Plc.
Previously, Mr. Hopkins worked as the Vice President-Investor Relations at Synergy Pharmaceuticals LLC.
Aktive Positionen von Gem Hopkins
Unternehmen | Position | Beginn |
---|---|---|
SILENCE THERAPEUTICS PLC | Investor Relations Kontakt | 01.08.2020 |
Ehemalige bekannte Positionen von Gem Hopkins
Unternehmen | Position | Ende |
---|---|---|
SYNERGY PHARMACEUTICALS INC | Investor Relations Kontakt | 01.11.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SILENCE THERAPEUTICS PLC | Commercial Services |
Private Unternehmen | 1 |
---|---|
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |